Tumor growth limited to subcutaneous site vs tumor growth in pulmonary site exhibit differential effects on systemic immunities

Liu, 2015, CD11b+Ly6G+ cells inhibit tumor growth by suppressing IL-17 production at early stages of tumorigenesis, OncoImmunology, 5, e1061175, 10.1080/2162402X.2015.1061175

Ostrand-Rosenberg, 2009, Myeloid-derived suppressor cells: Linking inflammation and cancer, J Immunol, 182, 4499, 10.4049/jimmunol.0802740

Mougiakakos, 2010, Regulatory T cells in cancer, Adv Cancer Res, 107, 57, 10.1016/S0065-230X(10)07003-X

Fichtner-Feigl, 2008, Restoration of tumor immunosurveillance via targeting of interleukin-13 receptor-alpha 2, Cancer Res, 68, 3467, 10.1158/0008-5472.CAN-07-5301

Nagaraj, 2010, Mechanism of T cell tolerance induced by myeloid-derived suppressor cells, J Immunol, 184, 3106, 10.4049/jimmunol.0902661

Alhamarneh, 2011, Serum IL10 and circulating CD4(+) CD25(high) regulatory T cell numbers as predictors of clinical outcome and survival in patients with head and neck squamous cell carcinoma, Head Neck, 33, 415, 10.1002/hed.21464

Shevach, 2000, Regulatory T cells in autoimmmunity, Annu Rev Immunol, 18, 423, 10.1146/annurev.immunol.18.1.423

Chen, 2011, Immuno-suppressive functions of hepatic myeloid-derived suppressor cells of normal mice and in a murine model of chronic hepatitis B virus, Clin Exp Immunol, 166, 134, 10.1111/j.1365-2249.2011.04445.x

Yu, 2013, Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer, J Immunol, 190, 3783, 10.4049/jimmunol.1201449

Tsiganov, 2014, Gr-1dimCD11b+ immature myeloid-derived suppressor cells but not neutrophils are markers of lethal tuberculosis infection in mice, J Immunol, 192, 4718, 10.4049/jimmunol.1301365

Youn, 2008, Subsets of myeloid-derived suppressor cells in tumor-bearing mice, J Immunol, 181, 5791, 10.4049/jimmunol.181.8.5791

Rutkowski, 2015, Microbially driven TLR5-dependent signaling governs distal malignant progression through tumor-promoting inflammation, Cancer Cell, 27, 27, 10.1016/j.ccell.2014.11.009

Wang, 2016, Myeloid-derived suppressor cells in patients with myeloproliferative neoplasm, Leuk Res, 43, 39, 10.1016/j.leukres.2016.02.004

Stiff, 2016, Myeloid-derived suppressor cells express Bruton's tyrosine kinase and can be depleted in tumor-bearing hosts by ibrutinib treatment, Cancer Res, 76, 2125, 10.1158/0008-5472.CAN-15-1490

Highfill, 2010, Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13, Blood, 116, 5738, 10.1182/blood-2010-06-287839

Pesu, 2008, T-cell-expressed proprotein convertase furin is essential for maintenance of peripheral immune tolerance, Nature, 455, 246, 10.1038/nature07210

Xu, 2010, Positive and negative transcriptional regulation of the Foxp3 gene is mediated by access and binding of the Smad3 protein to enhancer I, Immunity, 33, 313, 10.1016/j.immuni.2010.09.001

Alhamarneh, 2008, Regulatory T cells: What role do they play in antitumor immunity in patients with head and neck cancer?, Head Neck, 30, 251, 10.1002/hed.20739

Liu, 2008, A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells, Nat Immunol, 9, 632, 10.1038/ni.1607

Gabitass, 2011, Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13, Cancer Immunol Immunother, 60, 1419, 10.1007/s00262-011-1028-0

Yamazaki, 2009, EphA1 interacts with integrin-linked kinase and regulates cell morphology and motility, J Cell Sci, 122, 243, 10.1242/jcs.036467

Takayama, 2000, Mouse CD8+ CD122+ T cells with intermediate TCR increasing with age provide a source of early IFN-gamma production, J Immunol, 164, 5652, 10.4049/jimmunol.164.11.5652

Gabrilovich, 2009, Myeloid-derived suppressor cells as regulators of the immune system, Nat Rev Immunol, 9, 162, 10.1038/nri2506

Terabe, 2003, Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: Abrogation prevents tumor recurrence, J Exp Med, 198, 1741, 10.1084/jem.20022227

Holmgaard, 2015, Tumor-expressed IDO recruits and activates MDSCs in a Treg-dependent manner, Cell Rep, 13, 412, 10.1016/j.celrep.2015.08.077

Yao, 2015, Tr1 cells, but not Foxp3+ regulatory T cells, suppress NLRP3 inflammasome activation via an IL-10-dependent mechanism, J Immunol, 195, 488, 10.4049/jimmunol.1403225

Redford, 2011, The role of IL-10 in immune regulation during M. tuberculosis infection, Mucosal Immunol, 4, 261, 10.1038/mi.2011.7

Saraiva, 2010, The regulation of IL-10 production by immune cells, Nat Rev Immunol, 10, 170, 10.1038/nri2711

Beriou, 2010, TGF-beta induces IL-9 production from human Th17 cells, J Immunol, 185, 46, 10.4049/jimmunol.1000356

Zhao, 2015, Phenotype, development, and biological function of myeloid-derived suppressor cells, OncoImmunology, 5, e1004983, 10.1080/2162402X.2015.1004983

Heerboth, 2015, EMT and tumor metastasis, Clin Transl Med, 4, 6, 10.1186/s40169-015-0048-3

Li, 2014, Clinical significance of serum T helper 1/T helper 2 cytokine shift in patients with non-small cell lung cancer, Oncol Lett, 8, 1682, 10.3892/ol.2014.2391

Hong, 2013, Pretreatment levels of circulating Th1 and Th2 cytokines, and their ratios, are associated with ER-negative and triple negative breast cancers, Breast Cancer Res Treat, 139, 477, 10.1007/s10549-013-2549-3

Liang, 2011, Relationship between cytokine levels and clinical classification of gastric cancer, Asian Pac J Cancer Prev, 12, 1803

Seledtsov, 2015, Clinically feasible approaches to potentiating cancer cell-based immunotherapies, Hum Vaccin Immunother, 11, 851, 10.1080/21645515.2015.1009814

Sato, 1998, Impaired production of Th1 cytokines and increased frequency of Th2 subsets in PBMC from advanced cancer patients, Anticancer Res, 18D, 3951

Szaflarska, 2009, Preoperative plasma level of IL-10 but not of proinflammatory cytokines is an independent prognostic factor in patients with gastric cancer, Anticancer Res, 29, 5005

Kozłowski, 2003, Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients, Rocz Akad Med Bialymst, 48, 82

Asadullah, 2003, Interleukin-10 therapy - review of a new approach, Pharmacol Rev, 55, 241, 10.1124/pr.55.2.4

Habu, 2001, The mechanism of a defective IFN-γ response to bacterial toxins in an atopic dermatitis model, NC/Nga mice, and the therapeutic effect of IFN-γ, IL-12, or IL-18 on dermatitis, J Immunol, 166, 5439, 10.4049/jimmunol.166.9.5439

Noelle, 2010, Cellular sources and immune functions of interleukin-9, Nat Rev Immunol, 10, 683, 10.1038/nri2848

Lu, 2012, Th9 cells promote antitumor immune responses in vivo, J Clin Invest, 122, 4160, 10.1172/JCI65459

Huang, 2015, Association between low expression levels of interleukin-9 and colon cancer progression, Exp Ther Med, 10, 942, 10.3892/etm.2015.2588